Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N3OH
|
||||
Former ID |
DNC002332
|
||||
Drug Name |
A-317920
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Attention deficit hyperactivity disorder [ICD9: 314; ICD10:F90] | Investigative | [538727] | ||
Company |
Abbott
|
||||
Structure |
Download2D MOL |
||||
Formula |
C25H31N3O5
|
||||
InChI |
InChI=1S/C25H31N3O5/c1-18(26-24(30)22-4-2-16-33-22)25(31)28-14-12-27(13-15-28)11-3-17-32-21-9-7-20(8-10-21)23(29)19-5-6-19/h2,4,7-10,16,18-19H,3,5-6,11-15,17H2,1H3,(H,26,30)/t18-/m1/s1
|
||||
InChIKey |
RTRADBQSZJIRMT-GOSISDBHSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H3 receptor | Target Info | Antagonist | [536039] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.